Series B, led by Lightspeed Venture Partners, will turbocharge company’s rapid growth and extend their lead role in using AI to transform the patient experience—eliminating the stress tied to doctor’s appointments, lab tests, prescription renewals, physician referrals, and beyond—putting an end to the dreaded hold music

SAN FRANCISCO, Sept. 30, 2025 /PRNewswire/ — Assort Health, the most comprehensive patient experience platform powered by specialty-specific agentic AI, today announced the close of a $76 million Series B financing round led by Lightspeed Venture Partners, with investments by Felicis, First Round Capital, Chemistry, A*, Liquid2, and Quiet Capital. Galym Imanbayev, partner at Lightspeed Venture Partners, will join the board, and Paul Ricci, founding CEO of Nuance will be jo

See Full Page